MediWound (MDWD) Misses Q2 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. WDAY
2. NVDA
3. META
4. JNJ
5. AAPL
6. AMAT
7. SPY
8. ASML
9. NRIX
10. SUNS

Go back to MediWound (MDWD) Misses Q2 EPS by 11c

MediWound Reports Second Quarter 2016 Financial Results

July 28, 2016 6:45 AM EDT

YAVNE, Israel, July 28, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, reports financial results for the three and six months ended June 30, 2016.

Highlights of the second quarter of 2016 include:

Received positive reimbursement for NexoBrid® from the Board of the Italian Drug Agency (AIFA);Eleven presentations highlighting the positive results achieved by clinicians using NexoBrid as an effective enzymatic debridement for severe burns were presented during the American Burn... More